本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Altimmune, Inc.

5.01
-0.4250-7.83%
成交量:225.92萬
成交額:1,156.38萬
市值:3.85億
市盈率:-3.74
高:5.37
開:5.36
低:4.95
收:5.43
資料載入中...
2022/03/24

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/15

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/17

重要事件披露

8-K - Current report
2021/12/13

重要事件披露

8-K - Current report
2021/12/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

重要事件披露

8-K - Current report
2021/09/24

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

持股變動聲明

4 - Statement of changes in beneficial ownership of securities